STE Stock Overview
STERIS plc provides infection prevention and other procedural products and services worldwide.
STERIS plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$167.29|
|52 Week High||US$255.93|
|52 Week Low||US$162.19|
|1 Month Change||-16.77%|
|3 Month Change||-19.50%|
|1 Year Change||-24.03%|
|3 Year Change||17.99%|
|5 Year Change||89.24%|
|Change since IPO||8,011.03%|
Recent News & Updates
Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Summary STERIS has been traded down in recent months with sellers driving price action to the downside since April. Despite this, we believe shares still offer compelling value when examining STE's true corporate value. After reconciling GAAP accounting both investment value and continuing value [earnings] increase for the company. Shares, therefore, look fairly priced at $249 by estimate, and we rate STE a buy. Defensive healthcare also looks to catch a bid in a weaker economic outlook.
STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
STERIS plc's ( NYSE:STE ) periodic dividend will be increasing on the 23rd of September to $0.47, with investors...
STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
STERIS plc ( NYSE:STE ) will increase its dividend on the 23rd of September to $0.47, which is 9.3% higher than last...
|STE||US Medical Equipment||US Market|
Return vs Industry: STE exceeded the US Medical Equipment industry which returned -32.8% over the past year.
Return vs Market: STE underperformed the US Market which returned -23% over the past year.
|STE Average Weekly Movement||4.8%|
|Medical Equipment Industry Average Movement||8.5%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.8%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: STE is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: STE's weekly volatility (5%) has been stable over the past year.
About the Company
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
|STE fundamental statistics|
Is STE overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|STE income statement (TTM)|
|Cost of Revenue||US$2.67b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||3.77|
|Net Profit Margin||7.90%|
How did STE perform over the long term?See historical performance and comparison